Brief: N4 Pharma H1 Basic EPS GBP -0.002
24/09/2024 07:28
Sep 24 (Reuters) - N4 Pharma H1 basic EPS GBP -0.002. * H1 EPS GBP -0.002
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results